trazimera

Generic: trastuzumab-qyyp

Labeler: pfizer laboratories div pfizer inc
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name trazimera
Generic Name trastuzumab-qyyp
Labeler pfizer laboratories div pfizer inc
Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients

trastuzumab 150 mg/7.15mL

Manufacturer
Pfizer Laboratories Div Pfizer Inc

Identifiers & Regulatory

Product NDC 0069-0308
Product ID 0069-0308_d159ec9c-8cae-4bd1-9526-09b2d8c665fc
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761081
Listing Expiration 2026-12-31
Marketing Start 2021-03-10

Pharmacologic Class

Established (EPC)
her2/neu receptor antagonist [epc]
Mechanism of Action
her2/neu/cerbb2 antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00690308
Hyphenated Format 0069-0308

Supplemental Identifiers

RxCUI
2280732 2280737 2472791 2472794
UNII
P188ANX8CK
NUI
N0000175661 N0000020008

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name trazimera (source: ndc)
Generic Name trastuzumab-qyyp (source: ndc)
Application Number BLA761081 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 150 mg/7.15mL
source: ndc
Packaging
  • 1 VIAL in 1 CARTON (0069-0308-01) / 7.15 mL in 1 VIAL
source: ndc

Packages (1)

0069-0308-01 1 VIAL in 1 CARTON (0069-0308-01) / 7.15 mL in 1 VIAL

Ingredients (1)

trastuzumab (150 mg/7.15mL)

Linked Drug Pages (1)

Trazimera ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "d159ec9c-8cae-4bd1-9526-09b2d8c665fc", "openfda": {"nui": ["N0000175661", "N0000020008"], "unii": ["P188ANX8CK"], "rxcui": ["2280732", "2280737", "2472791", "2472794"], "spl_set_id": ["b9c5e894-27d2-4245-a653-df986fed3c56"], "pharm_class_epc": ["HER2/neu Receptor Antagonist [EPC]"], "pharm_class_moa": ["HER2/Neu/cerbB2 Antagonists [MoA]"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (0069-0308-01)  / 7.15 mL in 1 VIAL", "package_ndc": "0069-0308-01", "marketing_start_date": "20210310"}], "brand_name": "Trazimera", "product_id": "0069-0308_d159ec9c-8cae-4bd1-9526-09b2d8c665fc", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["HER2/Neu/cerbB2 Antagonists [MoA]", "HER2/neu Receptor Antagonist [EPC]"], "product_ndc": "0069-0308", "generic_name": "trastuzumab-qyyp", "labeler_name": "Pfizer Laboratories Div Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Trazimera", "active_ingredients": [{"name": "TRASTUZUMAB", "strength": "150 mg/7.15mL"}], "application_number": "BLA761081", "marketing_category": "BLA", "marketing_start_date": "20210310", "listing_expiration_date": "20261231"}